Clinical Trial Update: Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epacadostat with pembrolizumab and CRS-207, with or without cyclophosphamide and GVAX Pancreas vaccine, in metastatic pancreatic adenoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• CRS-207
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epacadostat (epacadostat)
• GVAX Pancreas Vaccine
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-06-20